A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE
A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE
SCMP Editorial
Opinion

Opinion

Editorial by SCMP Editorial

Poor countries need fair deal on vaccines

  • As companies race to find a ‘magic bullet’ for Covid-19, rich countries have bought the bulk of initial production, raising fears poverty-stricken populations may wait years for jabs

A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE
A Russian medical worker displays a trial Covid-19 vaccine. Russia registered the vaccine called Sputnik V in September 2020. Photo: EPA-EFE
READ FULL ARTICLE
SCMP Editorial

SCMP Editorial

Editorials represent the views of the South China Morning Post on the issues of the day.